LEETERS TO THE EDITOR

被引：4
作者：
Douxfils, Jonathan [1 ,2 ,3 ]
Beaudart, Charlotte [4 ,5 ]
Dogne, Jean-Michel [1 ]
机构：
[1] Univ Namur, Namur Res Inst Life Sci NARILIS, Fac Med, Dept Pharm,Clin Pharmacol & Toxicol Res Unit, Namur, Belgium
[2] QUALIblood SA, Namur, Belgium
[3] CHU Clermont Ferrand, Hop Estaing, Dept Biol Hematol, Clermont Ferrand, France
[4] Univ Liege, WHO Collaborating Ctr Epidemiol Musculoskeletal Hl, Div Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium
[5] Univ Namur, Namur Res Inst Life Sci NARILIS, Fac Med, Dept Biomed Sci,Clin Pharmacol & Toxicol Res Unit, Namur, Belgium
来源：
MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY | 2024年 / 31卷 / 08期
关键词：
D O I：
10.1097/GME.0000000000002404
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：734 / 735
页数：2
相关论文
共 5 条
[1]   Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause [J].
Cieri-Hutcherson, Nicole E. ;
Marji, Elaine K. ;
Hutcherson, Timothy C. .
MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2024, 31 (04) :342-354
[2]  
Douxfils J., 2023, Lancet, V402, P1623, DOI [10.1016/S0140-6736(23)01634-3, DOI 10.1016/S0140-6736(23)01634-3]
[3]  
European Medicines Agency, Veoza - Public Assessment Report
[4]  
Food and Drug Administration, Veozah - Clinical Review(s)
[5]   Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial [J].
Trower, Mike ;
Anderson, Richard A. ;
Ballantyne, Elizabeth ;
Joffe, Hadine ;
Kerr, Mary ;
Pawsey, Steve .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (05) :498-505
1